These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36864821)
1. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. Lomakin IB; Devarkar SC; Patel S; Grada A; Bunick CG Nucleic Acids Res; 2023 Apr; 51(6):2915-2930. PubMed ID: 36864821 [TBL] [Abstract][Full Text] [Related]
2. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris. Zhanel G; Critchley I; Lin LY; Alvandi N Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052 [TBL] [Abstract][Full Text] [Related]
3. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome. Batool Z; Lomakin IB; Polikanov YS; Bunick CG Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic basis for the translation inhibition of Cutibacterium acnes by Clindamycin. Lomakin IB; Devarkar SC; Grada A; Bunick CG J Invest Dermatol; 2024 Aug; ():. PubMed ID: 39122144 [TBL] [Abstract][Full Text] [Related]
5. Sarecycline hydrochloride for the treatment of acne vulgaris. Kaul G; Saxena D; Dasgupta A; Chopra S Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374 [TBL] [Abstract][Full Text] [Related]
7. Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris. Moore AY; Charles JEM; Moore S Future Microbiol; 2019 Sep; 14(14):1235-1242. PubMed ID: 31475868 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding Platsidaki E; Dessinioti C F1000Res; 2018; 7():. PubMed ID: 30613388 [TBL] [Abstract][Full Text] [Related]
13. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C; Katsambas A Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353 [TBL] [Abstract][Full Text] [Related]
14. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes. Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018 [TBL] [Abstract][Full Text] [Related]
15. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities. Cha H; Kim SK; Kook M; Yi TH Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375 [TBL] [Abstract][Full Text] [Related]